CCN2 and neoplasm: In particular, the CTGF expression at tumor areas was ~3.3-fold higher in the primary tumors with metastasis than those in the primary tumors without metastasis, and ~3-fold higher in the chemo-resistant tumors than those in the chemo-sensitive tumors (Figure 2A–2C).